Evaluating the Current Evidence for the Efficacy of Cannabis in Symptom Management of Endometriosis-Associated Pain
review
OA: gold
CC0
⤵ 1 in-corpus citation
AI-generated summary
This review of eight studies found that women with endometriosis commonly use cannabis for symptom relief, with some reporting reduced analgesic use.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
INTRODUCTION: Endometriosis is a chronic condition that affects millions of women in the United States. Chronic pain can be debilitating and complex to manage. Despite common approaches like hormonal treatments and surgery, many women continue to endure pain. Managing the chronic and multifaceted nature of endometriotic pain necessitates a comprehensive strategy.
METHODS: This study explores the potential of cannabis in alleviating endometriosis-related pain through an extensive literature search. Cohort studies, case-control studies, cross-sectional surveys, and systematic reviews from January 1996 to August 2022 were eligible for inclusion. Articles were then assessed and included for further analysis if they met the following criteria: (1) Population was women with endometriosis; (2) Discussed the therapeutic use of medical cannabis for endometriosis-related pain.
RESULTS: The literature search revealed 522 articles, with eight articles meeting criteria for analysis: four cross-sectional surveys, two systematic reviews, one retrospective cohort study, and one literature review. Cannabis consumption for symptom relief was common among women with endometriosis, and some even reported that the use of cannabis reduced their use of analgesics.
DISCUSSION: The use of cannabis for endometriosis-related pain holds significant promise for addressing the often-debilitating comfort experienced by those with this condition. By interacting with the endocannabinoid system, cannabis may provide relief by modulating pain perception, reducing inflammation, relaxing muscles, and alleviating neuropathic discomfort.
My notes (saved in your browser only)
Condition tags
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (26)
- Association of endocannabinoids with pain in endometriosis via openalex
- Cannabidiol for the Management of Endometriosis and Chronic Pelvic Pain via openalex
- Cannabinoids and chronic pelvic pain in women: Focus on endometriosis via openalex
- Cannabis Use, a Self-Management Strategy Among Australian Women With Endometriosis: Results From a National Online Survey via openalex
- Detection of Cannabinoid Receptor Expression by Endometriotic Lesions in Women with Endometriosis as an Alternative to Opioid-Based Pain Medication via openalex
- Effects of cannabis ingestion on endometriosis-associated pelvic pain and related symptoms via openalex
- Endometriosis: pathogenesis and treatment via openalex
- Impact of endometriosis on quality of life and work productivity: a multicenter study across ten countries via openalex
- Self-management strategies amongst Australian women with endometriosis: a national online survey via openalex
- The cannabinoid receptor CB<sub>1</sub>contributes to the development of ectopic lesions in a mouse model of endometriosis via openalex
- Use of Cannabis for Self-Management of Chronic Pelvic Pain via openalex
- W3167684799 via openalex
- W2112074033 via openalex
- W3207202320 via openalex
- W2082084857 via openalex
- W4205653617 via openalex
- W4210281247 via openalex
- W4210757569 via openalex
- W4225856147 via openalex
- W4280645308 via openalex
- W4281676448 via openalex
- W2964094455 via openalex
- W2913993799 via openalex
- W3095825531 via openalex
- W3107035738 via openalex
- W3108056904 via openalex
Cited by (1)
Source provenance
- europepmc
- last seen: 2026-06-16T06:07:01.518242+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pmc
- last seen: 2026-05-13T20:22:03.195721+00:00
- pubmed
- last seen: 2026-06-16T06:04:43.662205+00:00
License: CC0
· commercial use OK